INSMED INC Long-Term Debt
INSMED INC (INSM) had Long-Term Debt of $543.51 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-06
- 2026-06-30: Long-term Debt, Excluding Current Maturities $543.51M.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $542.22M.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $540.96M.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $539.72M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2026-06-30 | $543.51M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $542.22M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $540.96M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $539.72M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $538.51M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.11B 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.10B 10-K · filed 2026-02-19 |
| 2024-09-30 | $954.83M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $946.83M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $939.08M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.16B 10-K · filed 2025-02-20 |
| 2023-09-30 | $1.15B 10-Q · filed 2023-10-26 |
| 2023-06-30 | $1.14B 10-Q · filed 2023-08-03 |
| 2023-03-31 | $1.13B 10-Q · filed 2023-05-04 |
| 2022-12-31 | $1.13B 10-K · filed 2024-02-22 |
| 2022-09-30 | $784.80M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $783.98M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $783.16M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $566.59M 10-K · filed 2023-02-23 |
| 2021-09-30 | $557.60M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $548.75M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $361.57M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $356.32M 10-K · filed 2022-02-17 |
| 2020-09-30 | $351.13M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $346.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $340.94M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $335.94M 10-K · filed 2021-02-25 |
| 2019-09-30 | $331.00M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $326.13M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $321.31M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $316.56M 10-K · filed 2020-02-25 |
| 2018-09-30 | $311.86M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $307.16M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $302.71M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $55.57M 10-K · filed 2019-02-22 |
| 2017-09-30 | $55.39M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $55.19M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $54.99M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $54.79M 10-K · filed 2018-02-23 |
| 2016-09-30 | $34.68M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $16.14M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $19.11M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $22.03M 10-K · filed 2017-02-23 |
| 2014-12-31 | $24.86M 10-K · filed 2016-02-25 |
| 2014-09-30 | $14.71M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $16.49M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $14.57M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $16.34M 10-K · filed 2015-02-27 |
| 2013-09-30 | $12.54M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $14.89M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $14.51M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $16.22M 10-K · filed 2014-03-06 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |